Association between sleep apnea-specific hypoxic burden and severity of coronary artery disease
-
Published:2024-02-22
Issue:3
Volume:28
Page:1293-1301
-
ISSN:1520-9512
-
Container-title:Sleep and Breathing
-
language:en
-
Short-container-title:Sleep Breath
Author:
Zhang Hehe, Liu Honghong, Jiao Yuanni, Zhang Jing, Covassin Naima, Wang Mu, Lin Yun, Xie JiangORCID
Abstract
Abstract
Purpose
Sleep apnea-specific hypoxic burden (SASHB) is a polysomnographic metric that comprehensively measures the degree of nocturnal desaturation caused by obstructive sleep apnea. This research was conducted to elucidate the relationship between SASHB and coronary artery disease (CAD) severity.
Methods
We carried out a prospective study of hospitalized patients with CAD of unstable angina who were expected to undergo invasive coronary angiography at Beijing Anzhen Hospital from February to September 2023. SASHB values were calculated using a self-programmed C + + program. Multivariable logistic regression analysis was applied to identify the association between SASHB and the prevalence of severe CAD, documented by the Gensini Score, and the SYNTAX (Synergy between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) Score.
Results
This study enrolled 137 patients with a median age of 59 years, 96 (70.1%) of whom were male. A total of 125 (91.2%) patients had coronary stenosis of ≥ 50% in at least one location. Patients with a high SASHB of ≥ 18% min/h had a significantly higher Gensini Score (32.0 vs. 18.5, P = 0.002) and SYNTAX Score (14.0 vs. 7.0, P = 0.002) than those with a low SASHB. After adjusting for multiple covariates, a high SASHB was significantly associated with the prevalence of severe CAD, determined by a Gensini Score ≥ 21 (OR 2.67, P = 0.008) or a SYNTAX Score > 22 (OR 4.03, P = 0.016).
Conclusion
Our findings revealed a robust and independent association between SASHB and CAD severity in patients with unstable angina, highlighting the potential value of SASHB as a predictor of risk and a target for interventions aimed at preventing cardiovascular diseases.
Trial registration
Chinese Clinical Trial Registry No. ChiCTR2300067991 on February 2, 2023.
Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Rivera-Perez SJ, Martinez D, Araujo GN, Goncalves SC, Lazzaretti LK, Wainstein RV, Wainstein MV, Ribeiro JP (2019) Severity of obstructive sleep apnea and extension of coronary artery disease. Sleep Breath 23(3):747–752. https://doi.org/10.1007/s11325-018-1769-5 2. Newman SB, Kundel V, Matsuzaki M, Reid M, Kizer JR, Kaplan RC, Fayad ZA, Mani V, Shea S, Allison M, Criqui MH, Lutsey PL, McClelland RL, Redline S, Shah NA (2021) Sleep apnea, coronary artery calcium density, and cardiovascular events: results from the Multi-Ethnic Study of Atherosclerosis. J Clin Sleep Med 17(10):2075–2083. https://doi.org/10.5664/jcsm.9356 3. Zeng Y, Yang S, Wang X, Fan J, Nie S, Wei Y (2019) Prognostic impact of residual SYNTAX score in patients with obstructive sleep apnea and acute coronary syndrome: a prospective cohort study. Respir Res 20(1):43. https://doi.org/10.1186/s12931-019-1008-z 4. McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Zhang X, Mediano O, Chen R, Drager LF, Liu Z, Chen G, Du B, McArdle N, Mukherjee S, Tripathi M, Billot L, Li Q, Lorenzi-Filho G, Barbe F, Redline S, Wang J, Arima H, Neal B, White DP, Grunstein RR, Zhong N, Anderson CS, Investigators S, Coordinators (2016) CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med 375(10):919–931. https://doi.org/10.1056/NEJMoa1606599 5. Sanchez-de-la-Torre M, Sanchez-de-la-Torre A, Bertran S, Abad J, Duran-Cantolla J, Cabriada V, Mediano O, Masdeu MJ, Alonso ML, Masa JF, Barcelo A, de la Pena M, Mayos M, Coloma R, Montserrat JM, Chiner E, Perello S, Rubinos G, Minguez O, Pascual L, Cortijo A, Martinez D, Aldoma A, Dalmases M, McEvoy RD, Barbe F, Spanish Sleep N (2020) Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAACC study): a randomised controlled trial. Lancet Respir Med 8(4):359–367. https://doi.org/10.1016/S2213-2600(19)30271-1
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|